0001214659-22-013940.txt : 20221117 0001214659-22-013940.hdr.sgml : 20221117 20221117163023 ACCESSION NUMBER: 0001214659-22-013940 CONFORMED SUBMISSION TYPE: 4 PUBLIC DOCUMENT COUNT: 1 CONFORMED PERIOD OF REPORT: 20221115 FILED AS OF DATE: 20221117 DATE AS OF CHANGE: 20221117 REPORTING-OWNER: OWNER DATA: COMPANY CONFORMED NAME: GELFOND RICHARD L CENTRAL INDEX KEY: 0000944011 FILING VALUES: FORM TYPE: 4 SEC ACT: 1934 Act SEC FILE NUMBER: 001-35066 FILM NUMBER: 221398801 MAIL ADDRESS: STREET 1: 902 BROADWAY, 20TH FLOOR STREET 2: IMAX CORPORATION CITY: NEW YORK STATE: NY ZIP: 10010-6002 ISSUER: COMPANY DATA: COMPANY CONFORMED NAME: IMAX CORP CENTRAL INDEX KEY: 0000921582 STANDARD INDUSTRIAL CLASSIFICATION: PHOTOGRAPHIC EQUIPMENT & SUPPLIES [3861] IRS NUMBER: 980140269 STATE OF INCORPORATION: A6 FISCAL YEAR END: 1231 BUSINESS ADDRESS: STREET 1: 2525 SPEAKMAN DRIVE CITY: MISSISSAUGA STATE: A6 ZIP: L5K 1B1 BUSINESS PHONE: 9054036500 MAIL ADDRESS: STREET 1: 2525 SPEAKMAN DRIVE CITY: MISSISSAUGA STATE: A6 ZIP: L5K 1B1 4 1 marketforms-57574.xml PRIMARY DOCUMENT X0306 4 2022-11-15 0000921582 IMAX CORP IMAX 0000944011 GELFOND RICHARD L 902 BROADWAY 20TH FLOOR NEW YORK 10010-6002 true true false false Chief Executive Officer common shares (opening balance) 369987 D common shares 2022-11-15 4 G false 5000 0.00 D 364987 D common shares 2022-11-15 4 G false 5710 0.00 D 359277 D common shares 2022-11-16 4 G false 4290 0.00 D 354987 D On November 15, 2022, Mr. Gelfond gifted 5,000 common shares of IMAX Corporation to Stony Brook Foundation, a charitable organization. On November 15, 2022, Mr. Gelfond gifted 5,710 common shares of IMAX Corporation to the University at Buffalo Foundation, Inc., a charitable organization. On November 16, 2022, Mr. Gelfond gifted 4,290 common shares of IMAX Corporation to Wilkes University, a charitable organization. Mr. Gelfond's aggregate remaining outstanding option, restricted share unit and common share balances following these transactions will be 2,713,015, 314,394 and 354,987 respectively. /s/ Richard L. Gelfond 2022-11-17